about
Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR ImagesNew perspectives in glioblastoma antiangiogenic therapyGlioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic TargetsGlioma Stem Cells: Signaling, Microenvironment, and TherapyMechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiformeDynamic quantitative intravital imaging of glioblastoma progression reveals a lack of correlation between tumor growth and blood vessel densityThe mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma.Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsetsVascular Transdifferentiation in the CNS: A Focus on Neural and Glioblastoma Stem-Like CellsEndothelium-Independent Primitive Myxoid Vascularization Creates Invertebrate-Like Channels to Maintain Blood Supply in Optic Gliomas.Glioma-related edema: new insight into molecular mechanisms and their clinical implications.Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalingsKnockdown of P4HA1 inhibits neovascularization via targeting glioma stem cell-endothelial cell transdifferentiation and disrupting vascular basement membraneVascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in GlioblastomaNovel paracrine modulation of Notch-DLL4 signaling by fibulin-3 promotes angiogenesis in high-grade gliomas.Hemodynamic response imaging: a potential tool for the assessment of angiogenesis in brain tumorsCoibamide A, a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts.Impact of the biophysical features of a 3D gelatin microenvironment on glioblastoma malignancy.The challenges and the promise of molecular targeted therapy in malignant gliomas.Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma.Monitoring brain tumor vascular heamodynamic following anti-angiogenic therapy with advanced magnetic resonance imaging in mice.All-trans retinoic acid impairs the vasculogenic mimicry formation ability of U87 stem-like cells through promoting differentiation.A novel bispecific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells to target blood vessels and vasculogenic mimicry of malignant gliomas.Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma.ERG is a novel and reliable marker for endothelial cells in central nervous system tumorsImplications of neurovascular uncoupling in functional magnetic resonance imaging (fMRI) of brain tumors.A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatmentc-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastomaBrain Delivery of Drug and MRI Contrast Agent: Detection and Quantitative Determination of Brain Deposition of CPT-Glu Using LC-MS/MS and Gd-DTPA Using Magnetic Resonance Imaging.Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma.Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses.Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin.A role for ion channels in perivascular glioma invasion.Expressions of glia maturation factor-β by tumor cells and endothelia correlate with neovascularization and poor prognosis in human glioma.Update on bevacizumab and other angiogenesis inhibitors for brain cancer.Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments.Glioblastoma stem cells: Molecular characteristics and therapeutic implicationsGalectins and neovascularization in central nervous system tumors.
P2860
Q26743358-F67BDDF4-9E46-4F50-88C5-9A786104C7B3Q26746028-04B68AE5-DB05-4491-883B-F4ED8EB571F7Q26765758-EBC6A7EE-A260-4D42-B761-12323D77C5E4Q26765854-CE25BFCB-BDCA-40E4-9318-B11D0E10A7E2Q26824557-B3073235-8DCC-4D81-9961-7C72F9E7B820Q27308856-DA6BA80F-E51A-4904-99A8-3FBA714CE311Q27324657-746E8DE5-5578-45B3-9FC0-73B227954579Q27334435-461B7860-C14F-40B8-B09F-891AC7816154Q28072067-234BF0F5-3BB8-4244-8346-7E1772717076Q30402988-06EE2679-9514-42BB-8F28-B28E03C934A4Q30581454-0FB0B626-1A16-4A2A-8100-5F50EBC1A6D6Q33557623-7E63256E-5142-43B6-8125-FE0D7A55E669Q33829344-7F58AAB7-E64D-4030-A71E-445508578658Q33868524-7B18561E-2F4E-4841-9D3F-893AB4292503Q34287855-C721AFA5-6C0E-4B80-8EC3-A2688AC7B2C7Q34499649-DF137E0E-5ECB-4114-B4BB-365DC9850790Q34501525-65220177-C3B9-4E74-AE39-CDC0E8773ADEQ34655999-B4022A4E-95DD-47FA-B25F-E0F3E491D0C2Q35214534-7DB16724-393C-4CC8-9517-22F160008733Q35341639-DCE82B20-25C5-4209-888A-6C3266949938Q35519732-907343FF-DF34-4BAB-AEDB-4F76B387A582Q35628364-151DC97A-A49D-4821-98D1-E6402B5CAB4EQ35746801-8EAD6195-90C3-4D8F-A693-448BA438E921Q35863135-86E86814-40D5-4EBE-B6D9-17952EB50BEDQ35972990-2E5575F9-09DA-4CFE-A72C-02D8B2E3B0C6Q36368541-442D97CA-F2CA-451F-A08A-45CFCBC96493Q36544942-A9DAEB1A-BD8D-4B37-AF27-03DC7C1CB172Q36867324-83533190-0FDA-4071-A461-3D1BE7C127FBQ37072186-72E390F6-2518-4B37-99B9-725C3F706575Q37112714-5B1AB1AF-3C68-4D4A-8BC5-9373E7306747Q37153084-780EFFE0-87E3-41D0-B06A-1D54F330B7DCQ37362574-78973981-E39A-48A4-AAC3-DEE1D5A4BE34Q37601508-76ECC218-DFEB-40CE-9A1E-3021F8540F54Q37692451-99327F04-8F3B-4711-A5FB-AABA1D0F36B1Q37696664-67CDC43B-ADD3-4179-AF8F-BCC800B7E3BBQ37699121-FFAE1E00-334D-4809-B356-E04BB9E3482AQ38106370-6528B13B-0009-4609-9B25-237019230FD9Q38155932-DA6FCF6B-4302-4CFC-A826-2E99B09D99B1Q38207605-F2D7DB52-5C29-4E75-8CCC-F286D16E3C7EQ38214808-4E7EA095-67F3-44A5-8655-000D4A77B679
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Mechanisms of glioma-associated neovascularization.
@ast
Mechanisms of glioma-associated neovascularization.
@en
type
label
Mechanisms of glioma-associated neovascularization.
@ast
Mechanisms of glioma-associated neovascularization.
@en
prefLabel
Mechanisms of glioma-associated neovascularization.
@ast
Mechanisms of glioma-associated neovascularization.
@en
P2860
P1476
Mechanisms of glioma-associated neovascularization.
@en
P2093
David Zagzag
Matthew E Hardee
P2860
P304
P356
10.1016/J.AJPATH.2012.06.030
P407
P577
2012-08-02T00:00:00Z